← Back to Search

BAY94-9343 (Anetumab ravtansine) for Solid Tumors

Phase 2
Waitlist Available
Research Sponsored by Bayer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 3 years (from first study treatment until safety follow-up)
Awards & highlights

Study Summary

This study is evaluating whether anetumab ravtansine is safe and efficient for patients with solid tumors.

Eligible Conditions
  • Solid Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 3 years (from first study treatment until safety follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 3 years (from first study treatment until safety follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With TEAEs, TESAEs and Drug-related TEAEs and TESAEs
Secondary outcome measures
Overall Survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cancer patientsExperimental Treatment1 Intervention
Adult patients with solid cancer who received anetumab-ravtansine treatment in a completed Bayer study

Find a Location

Who is running the clinical trial?

BayerLead Sponsor
2,235 Previous Clinical Trials
25,325,554 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
2019. "A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03926143.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top